Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:01 PM
Ignite Modification Date:
2025-12-24 @ 4:01 PM
NCT ID:
NCT04695366
Eligibility Criteria:
Inclusion Criteria:
1. DLBCL diagnosed according to the WHO classification
2. Age \>18 years at diagnosis
3. Completed curative intent first line treatment with anthracycline-containing immuno-chemotherapy with or without consolidating radiotherapy and achieved CR on end-of-treatment CT/PET-CT scan, as recorded in the medical record by the treating physician.
4. Participated in less than 2 years of follow-up without biopsy-verified relapse
5. Access to electronic communication with health authorities (e-Boks - an electronic, closed two factor authentication)
6. Able to receive an email and complete a questionnaire in Danish
Exclusion Criteria:
1. Verified lymphoma in the central nervous system (CNS)
2. Initial treatment not completed
3. CR not reached after initial treatment
4. Palliative treatment including attenuated chemotherapy
5. Undergoing anti-lymphoma treatment or treatment for other cancer.
6. Inability to read Danish or no access to electronic communication
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04695366
Study Brief:
Protocol Section:
NCT04695366